1Bou G, Cervero G, Dominguez M A, et al. Characterization of a nosocomlial outbreak caused by a Multlresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme : high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J]. J Clin Microbil,2000,38(9):3299.
2Bergogne-berezin E, Towner K J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features [J]. Clin Microbiol Rev, 1996,9 ( 1 )148.
3Schreckenberger P C, Granevenitz A V. Acinetobacter,Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative Gram-negative rods [A]. In Murray P R,Baron E J, Pfaller M A, et al. Manual of Clinical microbiology [M]. 7th ed. Washington, D.C: American society for microbiology, 1999 : 539.
4National Committee for Clinical Laboratory Standards.Performance standards for antimicrobialsusceptibility testing[S]. 11th information supplment. M2-A7 and M7-A5. PA: Wayne,2001:46.
5Wang F, Zhu D M, Wu S, et al. Surveillance of bacterial resistance in Shanghai [J]. Chin J Infect Chemother,2002,2(1):1.
6Bou G, Oliver A, Maetinez-Beltran J. OXA-24, a novel class D β-lactamases with Carbapenemase activity in Acinetobacter baumanniii clinical strain [J]. Antimicrob Agents Chemother, 2000,44 (6) : 1556.
7Afzal-shah M, Woodford N, Livermore D M. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2001,45 (2): 583.
8Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, et al.The effects of test variables on the efficacy of hand hygiene agents [J]. Am J Infect Control,2004,32(2) : 69-83.
9Larson E. Hygiene of the skin: when is clean too clean[J].Emerg Infect Dis,2001, 7(2): 225-230.
10Kampf G. The six golden rules to improve compliance in hand hygiene[J]. J Hosp Infect,2004,56 Suppl 2: S3-S5.
